Literature DB >> 19357973

Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort.

Christin Heidemann1, Heiner Boeing, Tobias Pischon, Ute Nöthlings, Hans-Georg Joost, Matthias B Schulze.   

Abstract

To evaluate the impact of a recently developed, non-invasive risk score predictive for type 2 diabetes on the incidence and mortality of cardiovascular diseases and specific types of cancer. A total of 23,455 participants from the population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study aged 35-65 years and free of diabetes and major chronic diseases at baseline (1994-1998) were followed through 2006 for incident myocardial infarction, stroke, types of cancer, and death. Risk score points were assigned to each participant based on age, waist circumference, height, physical activity, history of hypertension, smoking, alcohol consumption, and intake of red meat, whole-grain bread, and coffee. Hazard ratios (HRs) were estimated by Cox regression models. In age- and sex-adjusted analyses, participants with a high risk score (5-year probability to develop diabetes > or = 10%) had significantly higher risks of myocardial infarction (HR 2.7, 95% CI 1.5-5.0) and stroke (1.9, 1.0-3.6), but not of colon, breast or prostate cancer incidence, than those with a low score (5-year probability < 1%). In addition, participants with a high risk score had considerably higher risks of cardiovascular (HR 4.6, 95% CI 2.3-9.4), cancer (1.7, 1.1-2.7), and total mortality (2.4, 1.8-3.4), the latter being equivalent to a difference in life expectancy of 13 years. These data indicate that a risk score predictive for type 2 diabetes is also related to elevated risks of myocardial infarction, stroke, and premature death in apparently healthy individuals and emphasize the need for early intervention in high-risk individuals.

Entities:  

Mesh:

Year:  2009        PMID: 19357973     DOI: 10.1007/s10654-009-9338-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  25 in total

1.  Assessing the impact of classical risk factors on myocardial infarction by rate advancement periods.

Authors:  A D Liese; H W Hense; H Brenner; H Löwel; U Keil
Journal:  Am J Epidemiol       Date:  2000-11-01       Impact factor: 4.897

2.  The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality.

Authors:  Karri Silventoinen; James Pankow; Jaana Lindström; Pekka Jousilahti; Gang Hu; Jaakko Tuomilehto
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2005-10

3.  Applying Cox regression to competing risks.

Authors:  M Lunn; D McNeil
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

4.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

Authors:  Susanna C Larsson; Nicola Orsini; Alicja Wolk
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

5.  An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes.

Authors:  Matthias B Schulze; Kurt Hoffmann; Heiner Boeing; Jakob Linseisen; Sabine Rohrmann; Matthias Möhlig; Andreas F H Pfeiffer; Joachim Spranger; Claus Thamer; Hans-Ulrich Häring; Andreas Fritsche; Hans-Georg Joost
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

6.  Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors:  Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

7.  The diabetes risk score: a practical tool to predict type 2 diabetes risk.

Authors:  Jaana Lindström; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

Review 8.  Primary prevention of colorectal cancer: lifestyle, nutrition, exercise.

Authors:  María Elena Martínez
Journal:  Recent Results Cancer Res       Date:  2005

Review 9.  Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.

Authors:  Edward Giovannucci
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

10.  Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models.

Authors:  Michael Stern; Ken Williams; David Eddy; Richard Kahn
Journal:  Diabetes Care       Date:  2008-05-28       Impact factor: 19.112

View more
  23 in total

Review 1.  Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies.

Authors:  Ying Jiang; Qiwen Ben; Hong Shen; Weiqi Lu; Yong Zhang; Jun Zhu
Journal:  Eur J Epidemiol       Date:  2011-09-22       Impact factor: 8.082

2.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design.

Authors:  Xin Gao; Albert Hofman; Yu Hu; Huandong Lin; Chouwen Zhu; Johannes Jeekel; Xuejuan Jin; Jiyao Wang; Jian Gao; Yiqing Yin; Naiqing Zhao
Journal:  Eur J Epidemiol       Date:  2010-12-01       Impact factor: 8.082

3.  The limitations of opportunistic epidemiology, pseudopod epidemiology.

Authors:  Lewis H Kuller
Journal:  Eur J Epidemiol       Date:  2016-09-03       Impact factor: 8.082

4.  Adherence to the WCRF/AICR cancer prevention recommendations and cancer-specific mortality: results from the Vitamins and Lifestyle (VITAL) Study.

Authors:  Theresa A Hastert; Shirley A A Beresford; Lianne Sheppard; Emily White
Journal:  Cancer Causes Control       Date:  2014-02-21       Impact factor: 2.506

5.  Impaired glucose tolerance in sleep disorders.

Authors:  Marietta Keckeis; Zuzana Lattova; Eszter Maurovich-Horvat; Pierre A Beitinger; Steffen Birkmann; Christoph J Lauer; Thomas C Wetter; Johanna Wilde-Frenz; Thomas Pollmächer
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

6.  Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Authors:  Kazuko Masuo
Journal:  Int J Hypertens       Date:  2010-10-21       Impact factor: 2.420

Review 7.  Early influences on cardiovascular and renal development.

Authors:  J J Miranda Geelhoed; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2010-09-25       Impact factor: 8.082

8.  Heart failure and the risk of stroke: the Rotterdam Study.

Authors:  V P Alberts; M J Bos; P J Koudstaal; A Hofman; J C M Witteman; B H C Stricker; M M B Breteler
Journal:  Eur J Epidemiol       Date:  2010-11       Impact factor: 8.082

9.  Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer.

Authors:  Theresa A Hastert; Shirley A A Beresford; Ruth E Patterson; Alan R Kristal; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-06-18       Impact factor: 4.254

10.  Diabetes mellitus and risk of brain tumors: A meta-analysis.

Authors:  Jiao Jian Tong; Huang Tao; Ouyang Tao Hui; Chen Jian
Journal:  Exp Ther Med       Date:  2012-09-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.